Combining BET inhibitors and PARP inhibitors might help patients resistant to chemotherapy, the study suggests.

The renovation project will restore the SCLC offices to their historic character, with National Park Service exhibits and educational signage. As part of the restoration and conservation of the lodge, ...

On March 7, 1965 protestors for African American voting rights were attacked by law enforcement officers in Selma, Alabama.

Lung cancer is the leading cause of cancer deaths among both men and women. Small-cell lung cancer (SCLC) and non-small-cell lung cancer (NSCLC) are the two main types of lung cancer. Most lung ...

IMFINZITM (durvalumab) has received approval in the European Union as a monotherapy for treating adults with limited-stage ...

Data from the study showed that treatment with Imfinzi led to statistically significant and clinically meaningful improvement in the OS and PFS in patients with LS-SCLC whose disease has not ...

Small cell lung cancer (SCLC) is one of the most recalcitrant cancers. SCLC patients usually present with extensive ...

Syndrome of Inappropriate Anti-Diuretic Hormone secretion, or SIADH, is a known complication of small-cell lung cancer (SCLC). SIADH makes your body produce too much of a hormone that causes your ...

The Roanoke Chapter of the Southern Christian Leadership Conference is commemorating the March 7, 1965, March for Voting ...

Small-cell lung cancer (SCLC) is an aggressive form of lung cancer with a high metastatic potential. Treatment with chemotherapy can produce high response rates, but potential relapse rates are ...

TAIPEI (Taiwan News) — A Taiwanese-led study published in Nature has found that small-cell lung cancer (SCLC) cells exhibit ...

AstraZeneca’s Imfinzi (durvalumab) has been approved in the European Union (EU) as monotherapy for the treatment of adults with limited-stage small cell lung cancer (LS-SCLC) whose disease has not ...